Cargando…
Breast Cancer Stem Cells as Drivers of Tumor Chemoresistance, Dormancy and Relapse: New Challenges and Therapeutic Opportunities
Breast cancer is the most frequent cancer among women worldwide. Therapeutic strategies to prevent or treat metastatic disease are still inadequate although great progress has been made in treating early-stage breast cancer. Cancer stem-like cells (CSCs) that are endowed with high plasticity and sel...
Autores principales: | De Angelis, Maria Laura, Francescangeli, Federica, Zeuner, Ann |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6826533/ https://www.ncbi.nlm.nih.gov/pubmed/31619007 http://dx.doi.org/10.3390/cancers11101569 |
Ejemplares similares
-
Stem Cell Plasticity and Dormancy in the Development of Cancer Therapy Resistance
por: De Angelis, Maria Laura, et al.
Publicado: (2019) -
Dormancy, stemness, and therapy resistance: interconnected players in cancer evolution
por: Francescangeli, Federica, et al.
Publicado: (2023) -
COVID-19: a potential driver of immune-mediated breast cancer recurrence?
por: Francescangeli, Federica, et al.
Publicado: (2020) -
Analysis of Dormancy-Associated Transcriptional Networks Reveals a Shared Quiescence Signature in Lung and Colorectal Cancer
por: Cuccu, Adriano, et al.
Publicado: (2022) -
COVID-19–Induced Modifications in the Tumor Microenvironment: Do They Affect Cancer Reawakening and Metastatic Relapse?
por: Francescangeli, Federica, et al.
Publicado: (2020)